CONCORD BIOTECH
Back to All Ratios
|
CONCORD BIOTECH Last 5 Year EBIT Growth History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
EBIT Growth(%) | 36.18 | -22.35 | 46.17 | - |
What is the latest EBIT Growth ratio of CONCORD BIOTECH ?
Year | EBIT Growth |
---|---|
Mar2023 | 36.18 |
Mar2022 | -22.35 |
Mar2021 | 46.17 |
Mar2020 | - |
How is EBIT Growth of CONCORD BIOTECH Trending?
Years | EBIT Growth | % Change | |
---|---|---|---|
Mar2023 | 36.18 | Positive | |
Mar2022 | -22.35 | Negative | |
Mar2021 | 46.17 | 0 | |
Mar2020 | 0 | - |
Other Financial Ratios of CONCORD BIOTECH
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹15,636.1 Cr | -0.4% | -5.3% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -0.4% |
-5.3% |
|
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses